|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.3 USD | -0.86% |
|
+4.53% | -2.63% |
| Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
| Apr. 24 | Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155 | MT |
Quest Diagnostics Incorporated reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 9,252 million compared to USD 9,883 million a year ago. Net income was USD 854 million compared to USD 946 million a year ago.
Basic earnings per share from continuing operations was USD 7.59 compared to USD 8.1 a year ago. Diluted earnings per share from continuing operations was USD 7.49 compared to USD 7.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.63% | 14.92B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B | |
| +27.44% | 11.71B |
QUEST DIAGNOSTICS INCORPORATED 
